Digitala Vetenskapliga Arkivet

Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Disproportionately raised risk of adverse outcomes in patients with COPD and comorbid type 2 diabetes or depression: Swedish register-based cohort study
Örebro Univ, Fac Med & Hlth, Sch Med Sci, Clin Epidemiol & Biostat, Örebro, Sweden.;Reg Varmland, Ctr Clin Res & Educ, Karlstad, Sweden..
Reg Varmland, Ctr Clin Res & Educ, Karlstad, Sweden.;Örebro Univ, Fac Med & Hlth, Sch Med Sci, Örebro, Sweden..
Karolinska Inst, Dept Neurobiol Care Sci & Soc, Div Family Med & Primary Care, Stockholm, Sweden.;Reg Stockholm, Acad Primary Hlth Care Ctr, Stockholm, Sweden..
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, General practice.ORCID iD: 0000-0001-8497-7326
Show others and affiliations
2025 (English)In: Respiratory Research, ISSN 1465-9921, E-ISSN 1465-993X, Vol. 26, no 1, article id 84Article in journal (Refereed) Published
Abstract [en]

Background

We aimed to examine if patients with COPD and comorbid type 2 diabetes, or COPD with comorbid depression or anxiety, had disproportionally raised excess risks of subsequent cardiovascular disease and mortality.

Methods

This general population-based cohort study used data from Swedish national registers, with follow-up during 2005-2018. Cox regression estimated risks of cardiovascular disease or mortality, producing hazard ratios (HR) with (95% confidence intervals). Interaction testing quantified disproportionally increased excess risks.

Results

Among 5,624,306 individuals, 332,549 had a COPD diagnosis. Compared with individuals who did not have COPD or type 2 diabetes, all-cause mortality risk was higher for individuals who had either COPD or type 2 diabetes, with HR 2.68 (2.66-2.69) and 1.70 (1.69-1.71), respectively. Having both conditions produced an HR of 3.72 (3.68-3.76). Among cardiovascular outcomes, the highest risks were found for chronic heart failure: COPD only, HR 2.87 (2.84-2.90); type 2 diabetes only, 1.86 (1.84-1.88); and both, 4.55 (4.46-4.64). Having both COPD and type 2 diabetes was associated with disproportionally higher excess risks than expected from the sum of the individual diseases, except for cerebrovascular disease or ischemic heart disease. For COPD and depression/anxiety, all-cause mortality risk was associated with COPD only, HR 2.74 (2.72-2.76); depression/anxiety only, 2.39 (2.38-2.40); and both 4.72 (4.68-4.75). Chronic heart failure was associated with COPD only, HR 2.74 (2.71-2.78); depression/anxiety only, 1.31 (1.30-1.32); and both, 3.45 (3.40-3.50). This disease combination was associated with disproportionally higher excess risks than expected, except for atrial fibrillation.

Conclusions

Type 2 diabetes or depression/anxiety in COPD patients were associated with disproportionally excess risks for cardiovascular disease and mortality. It is important for clinicians to be aware of these greater than expected risks, to prevent further cardiovascular morbidity and mortality.

Place, publisher, year, edition, pages
BioMed Central (BMC), 2025. Vol. 26, no 1, article id 84
Keywords [en]
COPD, Type 2 diabetes, Depression, Cardiovascular disease, Mortality
National Category
Respiratory Medicine and Allergy Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:uu:diva-553354DOI: 10.1186/s12931-025-03160-6ISI: 001439695500003PubMedID: 40045313Scopus ID: 2-s2.0-86000291992OAI: oai:DiVA.org:uu-553354DiVA, id: diva2:1948264
Funder
Swedish Research Council, 2023–05997Forte, Swedish Research Council for Health, Working Life and Welfare, 2019 -01236Region VärmlandAvailable from: 2025-03-28 Created: 2025-03-28 Last updated: 2025-03-28Bibliographically approved

Open Access in DiVA

fulltext(958 kB)23 downloads
File information
File name FULLTEXT01.pdfFile size 958 kBChecksum SHA-512
24c97d93246e743d981c67e30252e14b643cd3cdcb2c5c13b811386d720cd12f8eb4d68edee5e6523e3628bdca6c18dad5a579463c3b7778084c47425589d341
Type fulltextMimetype application/pdf

Other links

Publisher's full textPubMedScopus

Search in DiVA

By author/editor
Ställberg, Björn
By organisation
General practice
In the same journal
Respiratory Research
Respiratory Medicine and AllergyEndocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
Total: 23 downloads
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 216 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf